Concepedia
Statistics
Publications
36
Citations
4.6K
H-Index
25
Active since
1958
Affiliations
Princeton University(Current)
Hôpital Notre-Dame
Université de Montréal
University of Minnesota
Women's Health Research Institute
Suren N. Sehgal is an author at Princeton University specializing in medicine, pharmacology, and mtor inhibitor therapy.
Publications per year
1958–2003
Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
Claude Vézina, ALICIA KUDELSKI, Suren N. Sehgal · The Journal of Antibiotics · 1975 · 1.7K citations · Full text
Life Sciences, Biology, Microbiology +13
Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
Suren N. Sehgal, Hinton J. Baker, Claude Vézina · The Journal of Antibiotics · 1975 · 958 citations · Full text
Medicine, Medicinal Chemistry, Microbiology +8
Activity of rapamycin (AY-22,989) against transplanted tumors.
C. P. Eng, Suren N. Sehgal, Claude Vézina · The Journal of Antibiotics · 1984 · 341 citations · Full text
Medicine, Oncology, Pharmacology +7
Rapamycin Prolongs Survival and Arrests Pathophysiologic Changes in Murine Systemic Lupus Erythematosus
Linda M. Warner, Laurel M. Adams, Suren N. Sehgal · Arthritis & Rheumatism · 1994 · 178 citations
Medicine, Immunology, Pharmacology +17
Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation.
Hinton J. Baker, ANN SIDOROWICZ, Suren N. Sehgal et al. · The Journal of Antibiotics · 1978 · 164 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +9
1–5 of 36